New brain aneurysm device tested in tiny early study
NCT ID NCT07259018
First seen Jan 04, 2026 · Last updated Jun 23, 2026 · Updated 25 times
Summary
This early study tests a new device called the LuSeed Aneurysm Embolization System in 10 people with unruptured brain aneurysms. The device is inserted through a blood vessel to block the aneurysm and prevent it from bursting. The goal is to see if the procedure is safe and technically possible, not yet to prove it works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRUPTURED INTRACRANIAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Michael's Hospital - Unity Health Toronto
Toronto, Ontario, M5C 1R6, Canada
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LuSeed Aneurysm Embolization System (a device implanted via catheter to block blood flow to the aneurysm)
What this could lead to
If successful, this device could offer a new, less invasive treatment option for people with unruptured brain aneurysms.
What could go wrong
This is a very early feasibility study with only 10 people, so it is too small to prove the device works. Risks include stroke, device failure, or death.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.